Director of Mink Therapeutics
Organization: Mink Therapeutics
Peter Behner is Director of Mink Therapeutics.
Mr. Behner has been in equity partnership positions for the past 18 years at a number of global strategy and management consulting firms. Since July 2020 Mr. Behner has served as Global Health Sciences & Wellness Strategy and Transactions Leader at Ernst & Young. Mr. Behner joined Ernst & Young in September 2018 as the Global Transaction Services Leader for the Pharmaceutical and Lifesciences Industries.
From 2013 to June 2018 Mr. Behner was European Head of Health Industries and Consulting Leader for the Pharma & Lifesciences Industries for the EMEA region for Strategy&, a PricewaterhouseCoopers (PwC) company.
From 2005 until its 2013 acquisition by PwC, Mr. Behner was an equity partner at Booz & Company (BC), together with Booz Allen Hamilton (BAH) prior to BC’s spin-out from BAH. From 2003 to 2005 Mr. Behner was a partner at A.T. Kearney in its German Division, and from 2004 to 2005 he was Head of A.T. Kearney’s European Pharmaceutical and Life Science Industry group. Additionally, since April 2015, Mr. Behner has served as a Principal of Rottendorf GmbH, a pharmaceutical contract development and manufacturing company.
He holds a combined BE & ME degree in Mechanical Engineering for RWTH Aachen University in Germany.